Healthcare >> Money Manager Interviews >> April 28, 2003

Kurt Von Emster – Mpm Capital Lp

KURT VON EMSTER joined MPM Capital, LP, in November 2000 to extend their healthcare investment presence into the public markets. He is a General Partner of the MPM BioEquities Fund and manages several funds for MPM Advisors. He spent 11 years with Franklin Templeton Group as a Vice President and Portfolio Manager. At Franklin, Mr. von Emster managed over $2 billion in health and biotech funds, including the Franklin Biotechnology Discovery Fund and the Franklin Global Health Care Fund. Mr. von Emster holds the Chartered Financial Analyst designation, is a member of the Association for Investment Management and Research, and is a member of the Security Analysts of San Francisco. Mr. von Emster earned a degree from the University of California Santa Barbara in Business and Economics. Profile
TWST: Can you bring us up-to-date on MPM Capital and your

BioEquities Fund?

Mr. von Emster: The MPM BioEquities Fund is a predominantly long-

biased biotechnology fund. The Fund is invested